Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q2- Text added to 2021 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
AbbVie, Academy, American, Antitrust, baseline, case, consummated, Contemporaneously, Corlieve, country, customary, earlier, eligible, entitled, European, examination, exploit, forward, GC, higher, inflammation, intraocular, LA, meaningful, mild, Ophthalmology, path, Pennsylvania, prepaid, ratio, regular, repay, resolved, Rodino, SAS, satisfaction, Scale, settlement, suspension, TEAE, tiered, Union, uniQure, University, upfront, valid, waiting
Removed:
reclassified
Valuein 2021 Q2 filing- Value in 2021 Q3 filing
Original filings
Filing view